Extracorporeally induced total-body hyperthermia for disseminated cancer.
Koga S, Maeta M.
Adv Exp Med Biol. 1990;267:177-88. doi: 10.1007/978-1-4684-5766-7_16.
PMID:2088033
[Treatment of lung cancer by total-body hyperthermia using an extracorporeal circuit].
Maeta M.
Rinsho Kyobu Geka. 1989 Dec;9(6):540-4.
PMID:9308657
Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations.
Robins HI, Longo WL, Steeves RA, Cohen JD, Schmitt CL, Neville AJ, O'Keefe S, Lagoni R, Riggs C.
Int J Radiat Oncol Biol Phys. 1990 Apr;18(4):909-20. doi: 10.1016/0360-3016(90)90416-h.
PMID:2182581
Total-body hyperthermia with and without chemotherapy for advanced human neoplasms.
Barlogie B, Corry PM, Yip E, Lippman L, Johnston DA, Khalil K, Tenczynski TF, Reilly E, Lawson R, Dosik G, Rigor B, Hankenson R, Freireich EJ.
Cancer Res. 1979 May;39(5):1481-9.
PMID:218728
A reliable method for quantitating chromatin fragments by flow cytometry to predict the effect of total body irradiation and hyperthermia on mice.
Shen RN, Crabtree WN, Wu B, Young P, Sandison GA, Hornback NB, Shidnia H.
Int J Radiat Oncol Biol Phys. 1992;24(1):139-43. doi: 10.1016/0360-3016(92)91033-j.
PMID:1512150
Removal of DNA adducts.
Puri BK, Ijeh C, Monro JA.
Med Hypotheses. 2019 Jun;127:11-14. doi: 10.1016/j.mehy.2019.03.031. Epub 2019 Mar 27.